首页 > 最新文献

Annals of Gastroenterological Surgery最新文献

英文 中文
Survival Outcomes of Esophageal Squamous Cell Carcinoma Patients Who Underwent Salvage Esophagectomy: A Literature Review and Results From Two High-Volume Centers 食道鳞状细胞癌患者行补救性食管切除术的生存结局:两个大容量研究中心的文献综述和结果
IF 3.3 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-04-29 DOI: 10.1002/ags3.70028
Kotaro Sugawara, Koichi Yagi, Takashi Fukuda, Shoh Yajima, Daiji Oka, Yoshiyuki Miwa, Shuichiro Oya, Asami Okamoto, Raito Asaoka, Yoshifumi Baba

Background

This study aimed to investigate survival outcomes, the efficacy of lymph node (LN) dissection, and recurrence patterns in patients who underwent salvage surgery (SALV) for esophageal squamous cell carcinoma (ESCC) after definitive chemoradiotherapy (dCRT).

Methods

We retrospectively reviewed 69 patients with clinical stage I–IV thoracic ESCC who underwent SALV. Recurrence patterns and the distribution of LN metastases were analyzed according to the primary tumor location.

Results

The 90-day mortality rate was 2.9%, and the 3-year overall survival (OS) rate of the 69 patients was 47.1%. OS curves were significantly stratified by the presence of abdominal LN metastases (p = 0.007). Among six patients whose clinically positive LNs were not dissected because their swelling disappeared after dCRT (cN+/CRT-cN0 cases), two (33.3%) developed locoregional recurrence. In contrast, among 25 patients whose clinically positive LNs were dissected regardless of CRT-cN status, the incidence of locoregional recurrence alone was 4.0%. Patients with lower thoracic (Lt) tumors had a higher incidence of distant metastases than those with middle (Mt) or upper thoracic (Ut) tumors (61.5% vs. 36.8%/33.3%). Mediastinal LN metastases were rare (7.7%) in Lt tumors, whereas LN metastases were widely distributed within the regional zones in Mt/Ut tumors. Patients with Lt tumors and pathological LN metastases had extremely poor OS (3-year OS: 0%).

Conclusions

Abdominal LN metastases had a negative impact on survival in ESCC patients who underwent SALV. Clinically positive LNs should be dissected, provided it is technically feasible. The tumor location might influence the distribution and prognostic impact of pathological LN metastases.

背景:本研究旨在探讨食管癌(ESCC)患者在明确放化疗(dCRT)后接受挽救性手术(SALV)的生存结局、淋巴结(LN)清扫的疗效和复发模式。方法回顾性分析69例临床I-IV期ESCC行SALV手术的患者。根据原发肿瘤部位分析LN转移灶的复发模式及分布。结果69例患者90天死亡率为2.9%,3年总生存率为47.1%。OS曲线因腹部LN转移的存在而明显分层(p = 0.007)。在6例临床呈阳性的患者(cN+/CRT-cN0例)中,由于dCRT后肿胀消失而未切除的患者(cN+/CRT-cN0例),2例(33.3%)发生局部复发。相比之下,无论ct - cn状态如何,在25例临床阳性的患者中,仅局部复发的发生率为4.0%。下胸(Lt)肿瘤患者远端转移发生率高于中胸(Mt)或上胸(Ut)肿瘤患者(61.5% vs. 36.8%/33.3%)。Lt肿瘤中纵隔淋巴结转移罕见(7.7%),而Mt/Ut肿瘤中淋巴结转移广泛分布于区域内。Lt肿瘤和病理性LN转移患者的OS极差(3年OS: 0%)。结论腹腔淋巴结转移对接受SALV治疗的ESCC患者的生存有负面影响。如果技术可行,应解剖临床阳性的LNs。肿瘤的位置可能影响病理淋巴结转移的分布和预后。
{"title":"Survival Outcomes of Esophageal Squamous Cell Carcinoma Patients Who Underwent Salvage Esophagectomy: A Literature Review and Results From Two High-Volume Centers","authors":"Kotaro Sugawara,&nbsp;Koichi Yagi,&nbsp;Takashi Fukuda,&nbsp;Shoh Yajima,&nbsp;Daiji Oka,&nbsp;Yoshiyuki Miwa,&nbsp;Shuichiro Oya,&nbsp;Asami Okamoto,&nbsp;Raito Asaoka,&nbsp;Yoshifumi Baba","doi":"10.1002/ags3.70028","DOIUrl":"https://doi.org/10.1002/ags3.70028","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>This study aimed to investigate survival outcomes, the efficacy of lymph node (LN) dissection, and recurrence patterns in patients who underwent salvage surgery (SALV) for esophageal squamous cell carcinoma (ESCC) after definitive chemoradiotherapy (dCRT).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We retrospectively reviewed 69 patients with clinical stage I–IV thoracic ESCC who underwent SALV. Recurrence patterns and the distribution of LN metastases were analyzed according to the primary tumor location.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The 90-day mortality rate was 2.9%, and the 3-year overall survival (OS) rate of the 69 patients was 47.1%. OS curves were significantly stratified by the presence of abdominal LN metastases (<i>p</i> = 0.007). Among six patients whose clinically positive LNs were not dissected because their swelling disappeared after dCRT (cN+/CRT-cN0 cases), two (33.3%) developed locoregional recurrence. In contrast, among 25 patients whose clinically positive LNs were dissected regardless of CRT-cN status, the incidence of locoregional recurrence alone was 4.0%. Patients with lower thoracic (Lt) tumors had a higher incidence of distant metastases than those with middle (Mt) or upper thoracic (Ut) tumors (61.5% vs. 36.8%/33.3%). Mediastinal LN metastases were rare (7.7%) in Lt tumors, whereas LN metastases were widely distributed within the regional zones in Mt/Ut tumors. Patients with Lt tumors and pathological LN metastases had extremely poor OS (3-year OS: 0%).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Abdominal LN metastases had a negative impact on survival in ESCC patients who underwent SALV. Clinically positive LNs should be dissected, provided it is technically feasible. The tumor location might influence the distribution and prognostic impact of pathological LN metastases.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":"9 5","pages":"952-963"},"PeriodicalIF":3.3,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.70028","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145013268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship Between Kyphosis and Postoperative Gastroesophageal Reflux After Proximal Gastrectomy 胃近端切除术后后凸与胃食管反流的关系
IF 3.3 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-04-27 DOI: 10.1002/ags3.70032
Takaomi Ozawa, Suguru Maruyama, Katsutoshi Shoda, Yoshihiko Kawaguchi, Ryo Saito, Kensuke Shiraishi, Shinji Furuya, Hidetake Amemiya, Hiromichi Kawaida, Daisuke Ichikawa

Aim

The prevalence of kyphosis is increasing with increasing life expectancy. One of the most notable gastrointestinal complications is gastroesophageal reflux disease (GERD) in patients with kyphosis. In this study, we investigated the association between kyphosis and the incidence of postoperative GERD in patients who underwent proximal gastrectomy (PG), a procedure with a particularly high risk of GERD.

Methods

In total, 54 consecutive patients who underwent PG between 2009 and 2023 met the inclusion criteria. The thoracic/lumbar angle ratio (T/L ratio) derived from sagittal computed tomography was performed to preoperatively assess kyphosis, defined as a T/L ratio ≥ 1.25.

Results

Fifteen patients (27.8%) had kyphosis. Overall, postoperative GERD occurred in seven patients (13.0%). Preoperative albumin levels were significantly lower in the Kyphosis group than in the Normal group (p = 0.03), whereas other clinical characteristics showed no significant differences between the two groups. The incidence of postoperative GERD was significantly higher in the Kyphosis group than in the Normal group (33.3% vs. 5.1%, p = 0.01). Postoperative reflux symptoms also were more frequently observed in the Kyphosis group than in the Normal group (60.0% vs. 16.0%, p = 0.13). Kyphosis was one of the independent predictive factors for postoperative GERD (Odds ratio, 18.7; 95% confidence interval, 1.46–240; p = 0.02) in the multivariate analysis.

Conclusion

Kyphosis was significantly associated with the occurrence of postoperative GERD in patients who underwent PG. Alternative preventive measures may be considered when patients with kyphosis undergo PG.

目的随着预期寿命的延长,脊柱后凸的发病率呈上升趋势。后凸患者最显著的胃肠道并发症之一是胃食管反流病(GERD)。在这项研究中,我们调查了接受近端胃切除术(PG)的患者后凸与术后胃反流发生率之间的关系,这是一种特别高风险的胃反流手术。方法在2009年至2023年期间,共有54例连续接受PG的患者符合纳入标准。术前进行矢状位计算机断层扫描得出的胸腰椎角度比(T/L比)评估后凸,定义为T/L比≥1.25。结果15例(27.8%)出现后凸。总体而言,7例(13.0%)患者发生术后反流。后凸组术前白蛋白水平明显低于正常组(p = 0.03),而其他临床特征在两组间无显著差异。后凸组术后胃食管反流发生率明显高于正常组(33.3% vs. 5.1%, p = 0.01)。术后反流症状在后凸组也比正常组更常见(60.0%比16.0%,p = 0.13)。多因素分析中,后凸是术后胃食管反流的独立预测因素之一(优势比18.7;95%可信区间1.46 ~ 240;p = 0.02)。结论脊柱后凸与PG术后胃食管反流的发生有显著相关性,脊柱后凸患者行PG时可考虑采取其他预防措施。
{"title":"Relationship Between Kyphosis and Postoperative Gastroesophageal Reflux After Proximal Gastrectomy","authors":"Takaomi Ozawa,&nbsp;Suguru Maruyama,&nbsp;Katsutoshi Shoda,&nbsp;Yoshihiko Kawaguchi,&nbsp;Ryo Saito,&nbsp;Kensuke Shiraishi,&nbsp;Shinji Furuya,&nbsp;Hidetake Amemiya,&nbsp;Hiromichi Kawaida,&nbsp;Daisuke Ichikawa","doi":"10.1002/ags3.70032","DOIUrl":"https://doi.org/10.1002/ags3.70032","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>The prevalence of kyphosis is increasing with increasing life expectancy. One of the most notable gastrointestinal complications is gastroesophageal reflux disease (GERD) in patients with kyphosis. In this study, we investigated the association between kyphosis and the incidence of postoperative GERD in patients who underwent proximal gastrectomy (PG), a procedure with a particularly high risk of GERD.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>In total, 54 consecutive patients who underwent PG between 2009 and 2023 met the inclusion criteria. The thoracic/lumbar angle ratio (T/L ratio) derived from sagittal computed tomography was performed to preoperatively assess kyphosis, defined as a T/L ratio ≥ 1.25.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Fifteen patients (27.8%) had kyphosis. Overall, postoperative GERD occurred in seven patients (13.0%). Preoperative albumin levels were significantly lower in the Kyphosis group than in the Normal group (<i>p</i> = 0.03), whereas other clinical characteristics showed no significant differences between the two groups. The incidence of postoperative GERD was significantly higher in the Kyphosis group than in the Normal group (33.3% vs. 5.1%, <i>p</i> = 0.01). Postoperative reflux symptoms also were more frequently observed in the Kyphosis group than in the Normal group (60.0% vs. 16.0%, <i>p</i> = 0.13). Kyphosis was one of the independent predictive factors for postoperative GERD (Odds ratio, 18.7; 95% confidence interval, 1.46–240; <i>p</i> = 0.02) in the multivariate analysis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Kyphosis was significantly associated with the occurrence of postoperative GERD in patients who underwent PG. Alternative preventive measures may be considered when patients with kyphosis undergo PG.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":"9 5","pages":"964-970"},"PeriodicalIF":3.3,"publicationDate":"2025-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.70032","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145013239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nationwide Trends in Short-Term Outcomes After Low Anterior Resection for Rectal Cancer: A Pre- and Post-COVID-19 Analysis From the Japanese National Clinical Database, 2018–2023 全国范围内直肠癌低位前切除术后短期结果的趋势:2018-2023年日本国家临床数据库中covid -19前后的分析
IF 3.3 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-04-25 DOI: 10.1002/ags3.70031
Ryo Seishima, Hideki Endo, Hiromichi Maeda, Taizo Hibi, Masashi Takeuchi, Yusuke Takemura, Hiroyuki Yamamoto, Akinobu Taketomi, Yoshihiro Kakeji, Yasuyuki Seto, Hideki Ueno, Masaki Mori, Ken Shirabe, Yuko Kitagawa

Aim

This study evaluated the short-term outcomes of low anterior resection for rectal cancer in Japan before and after the COVID-19 pandemic, with a particular focus on the timing of its reclassification within Japan in May 2023.

Methods

Using data from the Japanese National Clinical Database, we analyzed 109 754 low anterior resection cases between January 2018 and December 2023, categorized into pre-pandemic (February 2020 and earlier), pandemic (March 2020–April 2023), and post-pandemic (May 2023 onward) periods. Trends in the number of low anterior resection cases, postoperative intensive care unit utilization, and complications, including anastomotic leakage and pneumonia, were examined. Standardized morbidity ratios were used to adjust for risk and assess trends over time.

Results

The number of low anterior resection cases declined during the pandemic but returned to pre-pandemic levels thereafter. The postoperative intensive care unit admission rates remained stable, with a slight increase post-pandemic. The incidence of major complications gradually declined from pre-pandemic to post-pandemic, with anastomotic leakage rates decreasing from 9.8% to 7.1% and the standardized morbidity ratio for anastomotic leakage decreasing from 1.0 to 0.8, reflecting improved outcomes. The number of robot-assisted surgeries significantly increased from 246 cases in March 2020 to 535 in May 2023, and their proportion among total surgeries also rose from 16.8% to 41.2%.

Conclusion

Despite initial challenges, the healthcare system of Japan effectively managed rectal cancer surgeries during and after the pandemic. Robotic surgery became more widely adopted, and complication rates improved, demonstrating resilience and adaptability in surgical care.

本研究评估了2019冠状病毒病大流行前后日本直肠癌低位前切除术的短期效果,特别关注了2023年5月在日本重新分类的时间。方法利用日本国家临床数据库的数据,分析2018年1月至2023年12月期间109 754例低位前切除术病例,分为大流行前(2020年2月及更早)、大流行前(2020年3月至2023年4月)和大流行后(2023年5月以后)时期。对低位前切除术病例数、术后重症监护病房使用率以及吻合口漏和肺炎等并发症的趋势进行了分析。标准化发病率用于调整风险和评估随时间变化的趋势。结果大流行期间低位前切除术病例数下降,但大流行后恢复到大流行前水平。术后重症监护病房住院率保持稳定,大流行后略有增加。从流行前到流行后,主要并发症的发生率逐渐下降,吻合口瘘发生率从9.8%下降到7.1%,吻合口瘘标准化发病率从1.0下降到0.8,反映出预后的改善。机器人辅助手术数量从2020年3月的246例增加到2023年5月的535例,占总手术量的比例也从16.8%上升到41.2%。尽管最初面临挑战,日本的医疗保健系统在大流行期间和之后有效地管理了直肠癌手术。机器人手术得到更广泛的采用,并发症发生率有所提高,显示了手术护理的弹性和适应性。
{"title":"Nationwide Trends in Short-Term Outcomes After Low Anterior Resection for Rectal Cancer: A Pre- and Post-COVID-19 Analysis From the Japanese National Clinical Database, 2018–2023","authors":"Ryo Seishima,&nbsp;Hideki Endo,&nbsp;Hiromichi Maeda,&nbsp;Taizo Hibi,&nbsp;Masashi Takeuchi,&nbsp;Yusuke Takemura,&nbsp;Hiroyuki Yamamoto,&nbsp;Akinobu Taketomi,&nbsp;Yoshihiro Kakeji,&nbsp;Yasuyuki Seto,&nbsp;Hideki Ueno,&nbsp;Masaki Mori,&nbsp;Ken Shirabe,&nbsp;Yuko Kitagawa","doi":"10.1002/ags3.70031","DOIUrl":"https://doi.org/10.1002/ags3.70031","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>This study evaluated the short-term outcomes of low anterior resection for rectal cancer in Japan before and after the COVID-19 pandemic, with a particular focus on the timing of its reclassification within Japan in May 2023.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Using data from the Japanese National Clinical Database, we analyzed 109 754 low anterior resection cases between January 2018 and December 2023, categorized into pre-pandemic (February 2020 and earlier), pandemic (March 2020–April 2023), and post-pandemic (May 2023 onward) periods. Trends in the number of low anterior resection cases, postoperative intensive care unit utilization, and complications, including anastomotic leakage and pneumonia, were examined. Standardized morbidity ratios were used to adjust for risk and assess trends over time.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The number of low anterior resection cases declined during the pandemic but returned to pre-pandemic levels thereafter. The postoperative intensive care unit admission rates remained stable, with a slight increase post-pandemic. The incidence of major complications gradually declined from pre-pandemic to post-pandemic, with anastomotic leakage rates decreasing from 9.8% to 7.1% and the standardized morbidity ratio for anastomotic leakage decreasing from 1.0 to 0.8, reflecting improved outcomes. The number of robot-assisted surgeries significantly increased from 246 cases in March 2020 to 535 in May 2023, and their proportion among total surgeries also rose from 16.8% to 41.2%.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Despite initial challenges, the healthcare system of Japan effectively managed rectal cancer surgeries during and after the pandemic. Robotic surgery became more widely adopted, and complication rates improved, demonstrating resilience and adaptability in surgical care.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":"9 5","pages":"1029-1035"},"PeriodicalIF":3.3,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.70031","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145013113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimal Extent of Lymph Node Dissection for Non-Metastatic Colon Cancer by Tumor Location: Evaluation of the Therapeutic Value Index for Each Lymph Node Station 非转移性结肠癌肿瘤部位淋巴结清扫的最佳范围:各淋巴结站治疗价值指数的评价
IF 3.3 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-04-21 DOI: 10.1002/ags3.70023
Akira Ouchi, Kozo Kataoka, Eiji Shinto, Takashi Akiyoshi, Takefumi Yoshida, Yasuyuki Takamizawa, Yukihide Kanemitsu, Hirotoshi Kobayashi, Yoichi Ajioka, the Lymph Nodes Committee of JSCCR

Aims

To determine the optimal extent of lymph node dissection for non-metastatic colon cancer by tumor location based on the therapeutic value index (TVI) for each lymph node station.

Methods

Consecutive patients with surgical stage I–III colon or rectosigmoid cancer in the Japanese Society for Cancer of the Colon and Rectum database who underwent curative resection between January 2003 and December 2014 were analyzed. The TVI was defined as the incidence of lymph node metastasis multiplied by 5-year overall survival and calculated for each nodal station stratified by tumor location.

Results

A total of 33 231 patients were eligible for analysis. In cecal cancer, the TVI was 2.086 for nodal station #203, but only 0.000 for #213. In ascending colon cancer, the TVI was 1.080 for #203 and 0.644 for #213, but only 0.178 for #223. In transverse colon cancer, the TVI was 1.942 for #223, but only 0.066 for #213 and 0.159 for #203. In descending colon cancer, the TVI was 0.215 for #253. The TVI was 1.172 for #253 in sigmoid colon cancer and 1.155 for #253 in rectosigmoid cancer.

Conclusion

Considering that a previous systematic review reported TVIs in the range of 0.295–0.576 for the para-aortic lymph nodes in patients with colorectal cancer, dissection of the main lymph nodes along the feeding artery has a therapeutic value in non-metastatic colon cancers. Meanwhile, the significance of #253 dissection for descending colon cancer requires further discussion.

目的根据各淋巴结站的治疗价值指数(therapeutic value index, TVI)确定肿瘤部位非转移性结肠癌的最佳淋巴结清扫程度。方法对2003年1月至2014年12月日本结直肠癌症协会数据库中连续行根治性手术切除的I-III期结肠癌或直肠乙状结肠癌患者进行分析。TVI定义为淋巴结转移发生率乘以5年总生存率,并按肿瘤位置分层计算每个淋巴结站。结果共有33 231例患者符合分析条件。盲肠癌203节点站TVI为2.086,213节点站TVI仅为0.000。在升结肠癌中,203号的TVI为1.080,213号为0.644,而223号仅为0.178。在横断面结肠癌中,223号的TVI为1.942,而213号和203号的TVI仅为0.066和0.159。在降结肠癌中,253号患者的TVI为0.215。#253乙状结肠的TVI为1.172,#253直肠乙状结肠的TVI为1.155。结论考虑到已有系统综述报道结直肠癌主动脉旁淋巴结TVIs在0.295 ~ 0.576之间,沿供血动脉清扫主淋巴结对非转移性结肠癌具有治疗价值。同时,253号夹层对降结肠癌的意义有待进一步探讨。
{"title":"Optimal Extent of Lymph Node Dissection for Non-Metastatic Colon Cancer by Tumor Location: Evaluation of the Therapeutic Value Index for Each Lymph Node Station","authors":"Akira Ouchi,&nbsp;Kozo Kataoka,&nbsp;Eiji Shinto,&nbsp;Takashi Akiyoshi,&nbsp;Takefumi Yoshida,&nbsp;Yasuyuki Takamizawa,&nbsp;Yukihide Kanemitsu,&nbsp;Hirotoshi Kobayashi,&nbsp;Yoichi Ajioka,&nbsp;the Lymph Nodes Committee of JSCCR","doi":"10.1002/ags3.70023","DOIUrl":"https://doi.org/10.1002/ags3.70023","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aims</h3>\u0000 \u0000 <p>To determine the optimal extent of lymph node dissection for non-metastatic colon cancer by tumor location based on the therapeutic value index (TVI) for each lymph node station.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Consecutive patients with surgical stage I–III colon or rectosigmoid cancer in the Japanese Society for Cancer of the Colon and Rectum database who underwent curative resection between January 2003 and December 2014 were analyzed. The TVI was defined as the incidence of lymph node metastasis multiplied by 5-year overall survival and calculated for each nodal station stratified by tumor location.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 33 231 patients were eligible for analysis. In cecal cancer, the TVI was 2.086 for nodal station #203, but only 0.000 for #213. In ascending colon cancer, the TVI was 1.080 for #203 and 0.644 for #213, but only 0.178 for #223. In transverse colon cancer, the TVI was 1.942 for #223, but only 0.066 for #213 and 0.159 for #203. In descending colon cancer, the TVI was 0.215 for #253. The TVI was 1.172 for #253 in sigmoid colon cancer and 1.155 for #253 in rectosigmoid cancer.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Considering that a previous systematic review reported TVIs in the range of 0.295–0.576 for the para-aortic lymph nodes in patients with colorectal cancer, dissection of the main lymph nodes along the feeding artery has a therapeutic value in non-metastatic colon cancers. Meanwhile, the significance of #253 dissection for descending colon cancer requires further discussion.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":"9 5","pages":"1008-1016"},"PeriodicalIF":3.3,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.70023","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145007995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
International Comparison of Geriatric-Associated Variables in Major Gastroenterological Surgery Between National Clinical Database and American College of Surgeons National Surgical Quality Improvement Program 国家临床数据库和美国外科医师学会国家手术质量改进计划在主要胃肠外科手术中老年相关变量的国际比较
IF 3.3 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-04-21 DOI: 10.1002/ags3.70021
Yasuhide Kofunato, Xane Peters, Arata Takahashi, Mark E. Cohen, Hiraku Kumamaru, Mitsukazu Gotoh, Yoshihiro Kakeji, Yasuyuki Seto, Yuko Kitagawa, Ken Shirabe, Hideki Ueno, Hiroaki Miyata, Clifford Y. Ko, Shigeru Marubashi

Backgrounds

Incidence of malignant disease in older patients has been increasing. These geriatric patients have more comorbidities and frailty than younger patients, necessitating different approaches in evaluation and treatment. Geriatric surgery studies in Japan have followed those conducted in the US. The aims of this study were to compare trends in geriatric variables for patients who underwent gastroenterological surgeries between two countries, and to elucidate the characteristics of them.

Study Design

Geriatric variables and outcomes were analyzed via nationwide databases in both countries. Subjects were defined as patients with age ≥ 65 who underwent seven major gastroenterological surgeries for malignant disease. Basic statistical values were compared between them.

Results

A total of 2703 patients in the National Clinical Database (NCD) and 1342 patients in the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) were included. Among preoperative comorbidities, dyspnea, hypertension, bleeding disorder, and emergency cases increased with age in both databases, while the rates of obesity and emergency cases were more frequent in NSQIP. Most postoperative complications were not significantly associated with age in either database. Geriatric-associated preoperative variables and outcomes varied with age in both countries. Cognitive variables (history of dementia, surrogate-signed consent, and delirium) were similar between the two databases. However, mobility elements (use of mobility aid, fall history, high fall risk, and new use of mobility aid) and postoperative functional dependency were more frequent in NSQIP than NCD.

Conclusion

Geriatric-associated variables and outcomes changed similarly with age in both countries, while mobility and function were different between the two.

背景:老年患者恶性疾病的发病率一直在上升。这些老年患者比年轻患者有更多的合并症和虚弱,需要不同的评估和治疗方法。日本的老年外科研究是继美国之后进行的。本研究的目的是比较两国接受胃肠外科手术患者的老年变量趋势,并阐明其特征。研究设计通过两国的全国数据库分析老年变量和结果。受试者定义为年龄≥65岁,因恶性疾病接受过7次大胃肠外科手术的患者。比较两组的基本统计值。结果共纳入美国国家临床数据库(NCD) 2703例患者和美国外科医师学会国家手术质量改进计划(NSQIP) 1342例患者。在术前合并症中,两个数据库中呼吸困难、高血压、出血性疾病和急诊病例均随年龄增长而增加,而NSQIP中肥胖和急诊病例的发生率更高。在两个数据库中,大多数术后并发症与年龄无关。在这两个国家,与老年相关的术前变量和结果因年龄而异。两个数据库的认知变量(痴呆史、代理签名同意书和谵妄)相似。然而,活动因素(使用活动辅助工具、跌倒史、高跌倒风险和新使用活动辅助工具)和术后功能依赖在NSQIP中比非传染性疾病更常见。结论:两国老年相关变量和结果随年龄变化相似,但活动能力和功能在两国之间存在差异。
{"title":"International Comparison of Geriatric-Associated Variables in Major Gastroenterological Surgery Between National Clinical Database and American College of Surgeons National Surgical Quality Improvement Program","authors":"Yasuhide Kofunato,&nbsp;Xane Peters,&nbsp;Arata Takahashi,&nbsp;Mark E. Cohen,&nbsp;Hiraku Kumamaru,&nbsp;Mitsukazu Gotoh,&nbsp;Yoshihiro Kakeji,&nbsp;Yasuyuki Seto,&nbsp;Yuko Kitagawa,&nbsp;Ken Shirabe,&nbsp;Hideki Ueno,&nbsp;Hiroaki Miyata,&nbsp;Clifford Y. Ko,&nbsp;Shigeru Marubashi","doi":"10.1002/ags3.70021","DOIUrl":"https://doi.org/10.1002/ags3.70021","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Backgrounds</h3>\u0000 \u0000 <p>Incidence of malignant disease in older patients has been increasing. These geriatric patients have more comorbidities and frailty than younger patients, necessitating different approaches in evaluation and treatment. Geriatric surgery studies in Japan have followed those conducted in the US. The aims of this study were to compare trends in geriatric variables for patients who underwent gastroenterological surgeries between two countries, and to elucidate the characteristics of them.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Study Design</h3>\u0000 \u0000 <p>Geriatric variables and outcomes were analyzed via nationwide databases in both countries. Subjects were defined as patients with age ≥ 65 who underwent seven major gastroenterological surgeries for malignant disease. Basic statistical values were compared between them.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 2703 patients in the National Clinical Database (NCD) and 1342 patients in the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) were included. Among preoperative comorbidities, dyspnea, hypertension, bleeding disorder, and emergency cases increased with age in both databases, while the rates of obesity and emergency cases were more frequent in NSQIP. Most postoperative complications were not significantly associated with age in either database. Geriatric-associated preoperative variables and outcomes varied with age in both countries. Cognitive variables (history of dementia, surrogate-signed consent, and delirium) were similar between the two databases. However, mobility elements (use of mobility aid, fall history, high fall risk, and new use of mobility aid) and postoperative functional dependency were more frequent in NSQIP than NCD.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Geriatric-associated variables and outcomes changed similarly with age in both countries, while mobility and function were different between the two.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":"9 5","pages":"1093-1103"},"PeriodicalIF":3.3,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.70021","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145013052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Essential Update 2023/2024: Multidisciplinary Treatment for Invasive Intraductal Papillary Mucinous Carcinoma 基本更新2023/2024:浸润性导管内乳头状粘液癌的多学科治疗
IF 2.9 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-04-21 DOI: 10.1002/ags3.70029
Seiko Hirono

Invasive intraductal papillary mucinous carcinoma (IPMC) has a high malignant potential, with surgical resection being the only potentially curative treatment. However, even after surgical resection, recurrence occurs frequently and the prognosis is poor once recurrence develops. While retrospective studies aiming to achieve long-term survival in invasive IPMC patients have been reported, the rarity of invasive IPMC has resulted in small-scale datasets, leading to low levels of evidence. Consequently, the utility of adjuvant therapy after surgery, neoadjuvant therapy (NAT) before surgery, and treatments for postoperative recurrence in invasive IPMC remains unclear, with treatment strategies varying by institution—ranging from surgical resection alone to approaches based on conventional pancreatic cancer treatment. Recently, several large-scale multicenter studies on invasive IPMC have been reported. These studies suggested that while adjuvant therapy after surgery may not be beneficial for all invasive IPMC patients, it could potentially extend survival in cases with advanced-stage disease. Regarding NAT before surgery for invasive IPMC, the number of reported cases is extremely limited, and no definitive evidence has been established. For postoperative recurrence of invasive IPMC, some studies have indicated that administering treatment may prolong survival. Although these large-scale studies have gradually clarified certain characteristics of invasive IPMC, they are all retrospective in nature, resulting in a low level of evidence. To achieve long-term survival for invasive IPMC patients, large-scale prospective multicenter studies are needed in the future.

侵袭性导管内乳头状粘液癌(IPMC)具有很高的恶性潜能,手术切除是唯一可能治愈的治疗方法。然而,即使在手术切除后,复发也很频繁,一旦复发预后较差。虽然已有旨在实现侵袭性IPMC患者长期生存的回顾性研究报道,但侵袭性IPMC的罕见性导致数据集规模小,证据水平低。因此,侵袭性IPMC术后辅助治疗、术前新辅助治疗(NAT)和术后复发治疗的应用仍不清楚,治疗策略因机构而异——从单纯手术切除到基于传统胰腺癌治疗的方法。近年来,有创性IPMC的多中心大规模研究报道。这些研究表明,虽然手术后辅助治疗可能不是对所有侵袭性IPMC患者都有益,但它可能会延长晚期疾病患者的生存期。关于侵袭性IPMC术前NAT,报道的病例数量非常有限,没有明确的证据。对于侵袭性IPMC术后复发,一些研究表明给予治疗可以延长生存期。虽然这些大规模的研究逐渐明确了侵袭性IPMC的某些特征,但它们都是回顾性的,证据水平较低。为了实现侵袭性IPMC患者的长期生存,未来需要进行大规模的前瞻性多中心研究。
{"title":"Essential Update 2023/2024: Multidisciplinary Treatment for Invasive Intraductal Papillary Mucinous Carcinoma","authors":"Seiko Hirono","doi":"10.1002/ags3.70029","DOIUrl":"https://doi.org/10.1002/ags3.70029","url":null,"abstract":"<p>Invasive intraductal papillary mucinous carcinoma (IPMC) has a high malignant potential, with surgical resection being the only potentially curative treatment. However, even after surgical resection, recurrence occurs frequently and the prognosis is poor once recurrence develops. While retrospective studies aiming to achieve long-term survival in invasive IPMC patients have been reported, the rarity of invasive IPMC has resulted in small-scale datasets, leading to low levels of evidence. Consequently, the utility of adjuvant therapy after surgery, neoadjuvant therapy (NAT) before surgery, and treatments for postoperative recurrence in invasive IPMC remains unclear, with treatment strategies varying by institution—ranging from surgical resection alone to approaches based on conventional pancreatic cancer treatment. Recently, several large-scale multicenter studies on invasive IPMC have been reported. These studies suggested that while adjuvant therapy after surgery may not be beneficial for all invasive IPMC patients, it could potentially extend survival in cases with advanced-stage disease. Regarding NAT before surgery for invasive IPMC, the number of reported cases is extremely limited, and no definitive evidence has been established. For postoperative recurrence of invasive IPMC, some studies have indicated that administering treatment may prolong survival. Although these large-scale studies have gradually clarified certain characteristics of invasive IPMC, they are all retrospective in nature, resulting in a low level of evidence. To achieve long-term survival for invasive IPMC patients, large-scale prospective multicenter studies are needed in the future.</p>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":"9 4","pages":"643-649"},"PeriodicalIF":2.9,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.70029","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144520007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Salvage esophagectomy for unresectable locally advanced esophageal squamous cell carcinoma: Significant or not? 挽救性食管切除术治疗局部晚期食管鳞状细胞癌:是否有意义?
IF 3.3 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-04-21 DOI: 10.1002/ags3.70013
Hiroshi Saeki, Makoto Sakai, Takayoshi Watanabe, Makoto Sohda, Ken Shirabe

We reviewed the current status and perspectives on salvage esophagectomy for initially unresectable locally advanced esophageal squamous cell carcinoma (ESCC) in the era of minimally invasive surgery and immunotherapy. Although the standard treatment for these patients is definitive chemoradiotherapy (CRT), the complete response rate to CRT alone remains unsatisfactory. Salvage esophagectomy, which is defined as surgery for residual or recurrent lesions after definitive CRT, is considered a curative treatment in clinical practice. No randomized trials have been conducted comparing salvage esophagectomy and non-surgical treatment in this cohort, because, in addition to the small number of eligible patients, constructing an appropriate study design may have been difficult. Therefore, in this review, the assessment of the current status was based on the results of several available retrospective studies. Most results from these studies show favorable results for salvage esophagectomy in this subject; however, whether it is a widely used treatment should be carefully evaluated because all these reports are limited to those from high-volume facilities for esophageal surgery. Appropriate patient selection and skilled surgical techniques are essential for successful salvage esophagectomy for initially unresectable locally advanced ESCC. To improve the short- and long-term outcomes of this surgery, advances in surgical techniques as well as further development of diagnostic capabilities, perioperative management, and multidisciplinary treatment are desirable.

我们综述了在微创手术和免疫治疗的时代,挽救性食管切除术治疗最初不可切除的局部晚期食管鳞状细胞癌(ESCC)的现状和前景。虽然这些患者的标准治疗是明确的放化疗(CRT),但单独使用CRT的完全缓解率仍然令人不满意。补救性食管切除术被定义为在明确的CRT后对残余或复发病变进行手术,在临床实践中被认为是一种治愈性治疗。在该队列中,没有进行随机试验来比较挽救性食管切除术和非手术治疗,因为除了符合条件的患者数量少之外,构建适当的研究设计可能很困难。因此,在本综述中,对现状的评估是基于几项现有回顾性研究的结果。这些研究的大多数结果显示挽救性食管切除术在这一主题中有良好的结果;然而,是否它是一种广泛使用的治疗方法应该仔细评估,因为所有这些报告都局限于那些来自大容量食道手术设施的报告。适当的患者选择和熟练的手术技术对于最初无法切除的局部晚期ESCC成功进行补救性食管切除术至关重要。为了改善该手术的短期和长期结果,需要外科技术的进步以及诊断能力、围手术期管理和多学科治疗的进一步发展。
{"title":"Salvage esophagectomy for unresectable locally advanced esophageal squamous cell carcinoma: Significant or not?","authors":"Hiroshi Saeki,&nbsp;Makoto Sakai,&nbsp;Takayoshi Watanabe,&nbsp;Makoto Sohda,&nbsp;Ken Shirabe","doi":"10.1002/ags3.70013","DOIUrl":"https://doi.org/10.1002/ags3.70013","url":null,"abstract":"<p>We reviewed the current status and perspectives on salvage esophagectomy for initially unresectable locally advanced esophageal squamous cell carcinoma (ESCC) in the era of minimally invasive surgery and immunotherapy. Although the standard treatment for these patients is definitive chemoradiotherapy (CRT), the complete response rate to CRT alone remains unsatisfactory. Salvage esophagectomy, which is defined as surgery for residual or recurrent lesions after definitive CRT, is considered a curative treatment in clinical practice. No randomized trials have been conducted comparing salvage esophagectomy and non-surgical treatment in this cohort, because, in addition to the small number of eligible patients, constructing an appropriate study design may have been difficult. Therefore, in this review, the assessment of the current status was based on the results of several available retrospective studies. Most results from these studies show favorable results for salvage esophagectomy in this subject; however, whether it is a widely used treatment should be carefully evaluated because all these reports are limited to those from high-volume facilities for esophageal surgery. Appropriate patient selection and skilled surgical techniques are essential for successful salvage esophagectomy for initially unresectable locally advanced ESCC. To improve the short- and long-term outcomes of this surgery, advances in surgical techniques as well as further development of diagnostic capabilities, perioperative management, and multidisciplinary treatment are desirable.</p>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":"9 5","pages":"894-902"},"PeriodicalIF":3.3,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.70013","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145013051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minimally Invasive Approach Utilizing Linear Stapler for Midline Incisional Hernia: Stapler Repair Technique 应用线性吻合器微创治疗中线切口疝:吻合器修复技术
IF 3.3 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-04-21 DOI: 10.1002/ags3.70026
Sho Ueda, Takuya Saito, Kohei Yasui, Kentaro Shinohara, Yasuyuki Fukami, Kenitiro Kaneko, Tsuyoshi Sano

Aim

We successfully established the stapler repair technique (SRT), a straightforward laparoscopic Rives-Stoppa approach utilizing a linear stapler. This study retrospectively evaluated its short-term outcomes to determine its safety and efficacy.

Methods

The surgical outcomes of 87 patients who underwent laparoscopic median incisional hernia repair at our hospital were reviewed between August 2017 and May 2024. Patients were treated with intraperitoneal onlay mesh (IPOM), laparoscopic trans-abdominal retromuscular (TARM), or SRT.

Results

Among these patients, 37 were treated with IPOM, 16 with TARM, and 34 with SRT, with no significant differences in patient characteristics. The median surgical time (range) was 96 min (50–211) for IPOM, 256 min (196–300) for TARM, and 112 min (60–289) for SRT, respectively. The median mesh areas (ranges) were 210 cm2 (80–500) for IPOM, 500 cm2 (270–780) for TARM, and 379 cm2 (176–864) for SRT, respectively. The SRT group had significantly shorter operative times (p < 0.001) and smaller mesh areas (p = 0.005) than the TARM group. Compared to the IPOM group, there was no significant difference in operative time in the SRT group (p = 0.444), but the mesh area was significantly larger (p < 0.001). The SRT group had no significant intraoperative complications or conversions to open surgery.

Conclusion

SRT offers a comparable operative time to IPOM and a significantly shorter time than TARM. Additionally, SRT can be performed extraperitoneally with no significant intraoperative complications or conversion to open surgery. These findings suggest that SRT is a safe and effective minimally invasive approach in median laparoscopic incisional hernia repair.

目的:我们成功地建立了吻合器修复技术(SRT),这是一种直接使用线性吻合器的腹腔镜rivers - stoppa方法。本研究回顾性评估了其短期疗效,以确定其安全性和有效性。方法回顾性分析2017年8月至2024年5月我院行腹腔镜正中切口疝修补术的87例患者的手术效果。患者接受腹腔内补片(IPOM)、腹腔镜下经腹肌后(TARM)或SRT治疗。结果IPOM组37例,TARM组16例,SRT组34例,患者特征无显著性差异。IPOM的中位手术时间(范围)分别为96分钟(50-211),TARM为256分钟(196-300),SRT为112分钟(60-289)。IPOM的中位网格面积(范围)为210 cm2 (80-500), TARM为500 cm2 (270-780), SRT为379 cm2(176-864)。SRT组手术时间明显短于TARM组(p < 0.001),补片面积明显小于TARM组(p = 0.005)。与IPOM组相比,SRT组手术时间差异无统计学意义(p = 0.444),但补片面积明显大于IPOM组(p < 0.001)。SRT组无明显术中并发症或转为开放手术。结论SRT的手术时间与IPOM相当,明显短于TARM。此外,SRT可以在腹膜外进行,没有明显的术中并发症或转换为开放手术。提示SRT是一种安全有效的微创腹腔镜切口疝修补方法。
{"title":"Minimally Invasive Approach Utilizing Linear Stapler for Midline Incisional Hernia: Stapler Repair Technique","authors":"Sho Ueda,&nbsp;Takuya Saito,&nbsp;Kohei Yasui,&nbsp;Kentaro Shinohara,&nbsp;Yasuyuki Fukami,&nbsp;Kenitiro Kaneko,&nbsp;Tsuyoshi Sano","doi":"10.1002/ags3.70026","DOIUrl":"https://doi.org/10.1002/ags3.70026","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>We successfully established the stapler repair technique (SRT), a straightforward laparoscopic Rives-Stoppa approach utilizing a linear stapler. This study retrospectively evaluated its short-term outcomes to determine its safety and efficacy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The surgical outcomes of 87 patients who underwent laparoscopic median incisional hernia repair at our hospital were reviewed between August 2017 and May 2024. Patients were treated with intraperitoneal onlay mesh (IPOM), laparoscopic trans-abdominal retromuscular (TARM), or SRT.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among these patients, 37 were treated with IPOM, 16 with TARM, and 34 with SRT, with no significant differences in patient characteristics. The median surgical time (range) was 96 min (50–211) for IPOM, 256 min (196–300) for TARM, and 112 min (60–289) for SRT, respectively. The median mesh areas (ranges) were 210 cm<sup>2</sup> (80–500) for IPOM, 500 cm<sup>2</sup> (270–780) for TARM, and 379 cm<sup>2</sup> (176–864) for SRT, respectively. The SRT group had significantly shorter operative times (<i>p</i> &lt; 0.001) and smaller mesh areas (<i>p</i> = 0.005) than the TARM group. Compared to the IPOM group, there was no significant difference in operative time in the SRT group (<i>p</i> = 0.444), but the mesh area was significantly larger (<i>p</i> &lt; 0.001). The SRT group had no significant intraoperative complications or conversions to open surgery.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>SRT offers a comparable operative time to IPOM and a significantly shorter time than TARM. Additionally, SRT can be performed extraperitoneally with no significant intraoperative complications or conversion to open surgery. These findings suggest that SRT is a safe and effective minimally invasive approach in median laparoscopic incisional hernia repair.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":"9 5","pages":"1086-1092"},"PeriodicalIF":3.3,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.70026","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145013049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Impact of Bone Mineral Density Reduction During Neoadjuvant Chemotherapy (NAC) in Patients Undergoing NAC Followed by Esophagectomy for Esophageal Cancer 食管癌患者行新辅助化疗(NAC)后食管癌切除术期间骨密度降低对预后的影响
IF 3.3 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-04-16 DOI: 10.1002/ags3.70025
Kazuhide Sato, Keita Takahashi, Yoshitaka Ishikawa, Naoko Fukushima, Takahiro Masuda, Takanori Kurogochi, Masami Yuda, Akira Matsumoto, Kazuto Tsuboi, Yuichiro Tanishima, Fumiaki Yano, Ken Eto

Background

Our previous study suggested that low bone mineral density (BMD), known as osteopenia, was a poor prognostic factor in patients who underwent esophagectomy for esophageal cancer (EC).

Meanwhile, the association between BMD reduction during neoadjuvant chemotherapy (NAC) and the worse prognosis remains unknown, although esophagectomy after NAC is the first option for the treatment of advanced esophageal squamous cell carcinoma (ESCC). Therefore, this study intended to investigate the prognostic impact of BMD reduction during NAC.

Method

A total of 101 ESCC patients who underwent curative Mckeown esophagectomy after NAC between January 2008 and December 2019 were analyzed. BMD reduction (+) was defined as ≥ 6.8% of the BMD reduction rate during NAC. The patients were classified into the BMD reduction (+) group (n = 32) and the BMD reduction (−) group (n = 69) by measuring the BMD reduction during NAC.

Results

Overall survival (OS) and relapse-free survival (RFS) in the BMD reduction (+) group were significantly worse than those in the BMD reduction (−) group (p < 0.01). In multivariate analysis, BMD reduction was associated with worse OS (Hazard ratio [HR], 2.95; 95% confidence interval [CI], 1.44–6.05) and RFS (HR, 2.29; 95% CI, 1.30–4.03). Moreover, low skeletal muscle index before NAC was an independent risk factor for BMD massive reduction (Odds ratio, 6.21; 95% CI, 2.10–18.30).

Conclusions

BMD reduction during NAC was considered to be an adverse prognostic factor for OS and RFS in patients underwent NAC followed by esophagectomy for ESCC.

我们之前的研究表明,低骨密度(BMD),即骨质减少,是食管癌(EC)行食管切除术患者预后不良的因素。同时,尽管NAC后食管切除术是晚期食管鳞状细胞癌(ESCC)治疗的首选,但新辅助化疗(NAC)期间BMD降低与预后不良之间的关系尚不清楚。因此,本研究旨在探讨NAC期间骨密度降低对预后的影响。方法回顾性分析2008年1月至2019年12月间行根治性Mckeown食管切除术的ESCC患者101例。骨密度降低(+)定义为NAC期间骨密度降低率≥6.8%。通过测定NAC期间的骨密度降低,将患者分为骨密度降低(+)组(n = 32)和骨密度降低(-)组(n = 69)。结果骨密度降低(+)组总生存期(OS)和无复发生存期(RFS)明显低于骨密度降低(-)组(p < 0.01)。在多变量分析中,骨密度降低与较差的OS(风险比[HR], 2.95; 95%可信区间[CI], 1.44-6.05)和RFS(风险比,2.29;95% CI, 1.30-4.03)相关。此外,NAC前的低骨骼肌指数是骨密度大量降低的独立危险因素(优势比6.21;95% CI 2.10-18.30)。结论:对于食管切除术后行食管切除术的ESCC患者,NAC期间BMD降低被认为是影响OS和RFS的不良预后因素。
{"title":"Prognostic Impact of Bone Mineral Density Reduction During Neoadjuvant Chemotherapy (NAC) in Patients Undergoing NAC Followed by Esophagectomy for Esophageal Cancer","authors":"Kazuhide Sato,&nbsp;Keita Takahashi,&nbsp;Yoshitaka Ishikawa,&nbsp;Naoko Fukushima,&nbsp;Takahiro Masuda,&nbsp;Takanori Kurogochi,&nbsp;Masami Yuda,&nbsp;Akira Matsumoto,&nbsp;Kazuto Tsuboi,&nbsp;Yuichiro Tanishima,&nbsp;Fumiaki Yano,&nbsp;Ken Eto","doi":"10.1002/ags3.70025","DOIUrl":"https://doi.org/10.1002/ags3.70025","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Our previous study suggested that low bone mineral density (BMD), known as osteopenia, was a poor prognostic factor in patients who underwent esophagectomy for esophageal cancer (EC).</p>\u0000 \u0000 <p>Meanwhile, the association between BMD reduction during neoadjuvant chemotherapy (NAC) and the worse prognosis remains unknown, although esophagectomy after NAC is the first option for the treatment of advanced esophageal squamous cell carcinoma (ESCC). Therefore, this study intended to investigate the prognostic impact of BMD reduction during NAC.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>A total of 101 ESCC patients who underwent curative Mckeown esophagectomy after NAC between January 2008 and December 2019 were analyzed. BMD reduction (+) was defined as ≥ 6.8% of the BMD reduction rate during NAC. The patients were classified into the BMD reduction (+) group (<i>n</i> = 32) and the BMD reduction (−) group (<i>n</i> = 69) by measuring the BMD reduction during NAC.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Overall survival (OS) and relapse-free survival (RFS) in the BMD reduction (+) group were significantly worse than those in the BMD reduction (−) group (<i>p</i> &lt; 0.01). In multivariate analysis, BMD reduction was associated with worse OS (Hazard ratio [HR], 2.95; 95% confidence interval [CI], 1.44–6.05) and RFS (HR, 2.29; 95% CI, 1.30–4.03). Moreover, low skeletal muscle index before NAC was an independent risk factor for BMD massive reduction (Odds ratio, 6.21; 95% CI, 2.10–18.30).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>BMD reduction during NAC was considered to be an adverse prognostic factor for OS and RFS in patients underwent NAC followed by esophagectomy for ESCC.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":"9 5","pages":"933-941"},"PeriodicalIF":3.3,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.70025","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145012754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Short- and Long-Term Outcomes of Open, Laparoscopic, and Robot-Assisted Surgery for Rectal Cancer 开放、腹腔镜和机器人辅助直肠癌手术的短期和长期结果
IF 3.3 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-04-16 DOI: 10.1002/ags3.70024
Marie Hanaoka, Hiroyasu Kagawa, Ataru Igarashi, Hiroshi Yoshihara, Shinichi Yamauchi, Masanori Tokunaga, Lin Peng-Lin, Minkyung Shin, Yusuke Kinugasa

Background

Robot-assisted surgery has short-term benefits in rectal cancer surgery; however, its long-term advantages remain unclear. This study compared short- and long-term outcomes of open, laparoscopic, and robot-assisted rectal cancer surgeries using large-scale, database-driven evidence.

Methods

Patients (28 711) diagnosed with clinical stages I–III rectal cancer who underwent rectal resection and were registered in the Japanese Medical Data Vision Co. Ltd. database were included. Open rectal resection (ORR), laparoscopic rectal resection (LRR), and robot-assisted rectal resection (RARR) were identified. The primary outcomes were 5-year overall survival (OS) and relapse-free survival (RFS). Secondary outcomes included perioperative outcomes.

Results

After applying overlap weight, the RARR, LRR, and ORR groups had 3635 (15.3%), 17 142 (72.3%), and 2935 (12.4%) patients, respectively. Among the cohort (mean age: 69.5 years), 64.9% were male, and 24.7%, 31.5%, and 43.8% had clinical stages I, II, and III, respectively. The RARR group demonstrated the lowest postoperative complication rate, 30- and 90-day mortality rates, and shortest hospital stay. The RARR group had the highest 5-year OS (95%) and RFS (93%) compared to LRR (OS: 89%, RFS: 86%) and ORR (OS: 81%, RFS: 77%; p < 0.001). Multivariable analysis revealed that RARR was significantly associated with improved OS, whereas higher risks were observed for LRR (hazard ratio [HR]: 2.18, 95% confidence interval [CI]: 1.69–2.81) and ORR (HR: 3.96, 95% CI: 3.03–5.19).

Conclusions

The RARR group demonstrated superior short- and long-term outcomes than the LRR and ORR groups, indicating robot-assisted surgery as a potential new standard treatment for rectal cancer.

机器人辅助手术在直肠癌手术中具有短期效益;然而,其长期优势仍不明朗。这项研究使用大规模的、数据库驱动的证据,比较了开放、腹腔镜和机器人辅助直肠癌手术的短期和长期结果。方法纳入日本医学数据视觉有限公司数据库中登记的28 711例临床诊断为I-III期直肠癌并行直肠切除术的患者。确定了开放直肠切除术(ORR)、腹腔镜直肠切除术(LRR)和机器人辅助直肠切除术(RARR)。主要结局为5年总生存期(OS)和无复发生存期(RFS)。次要结局包括围手术期结局。结果应用重叠权重后,RARR组3635例(15.3%),LRR组17142例(72.3%),ORR组2935例(12.4%)。在队列(平均年龄69.5岁)中,男性占64.9%,临床分期分别为I、II、III期,分别为24.7%、31.5%和43.8%。RARR组术后并发症发生率最低,30天和90天死亡率最低,住院时间最短。与LRR组(OS: 89%, RFS: 86%)和ORR组(OS: 81%, RFS: 77%; p < 0.001)相比,RARR组具有最高的5年OS(95%)和RFS(93%)。多变量分析显示,RARR与OS改善显著相关,而LRR(风险比[HR]: 2.18, 95%可信区间[CI]: 1.69 ~ 2.81)和ORR(风险比:3.96,95% CI: 3.03 ~ 5.19)的风险更高。结论RARR组的短期和长期预后优于LRR和ORR组,表明机器人辅助手术可能是直肠癌的新标准治疗方法。
{"title":"Short- and Long-Term Outcomes of Open, Laparoscopic, and Robot-Assisted Surgery for Rectal Cancer","authors":"Marie Hanaoka,&nbsp;Hiroyasu Kagawa,&nbsp;Ataru Igarashi,&nbsp;Hiroshi Yoshihara,&nbsp;Shinichi Yamauchi,&nbsp;Masanori Tokunaga,&nbsp;Lin Peng-Lin,&nbsp;Minkyung Shin,&nbsp;Yusuke Kinugasa","doi":"10.1002/ags3.70024","DOIUrl":"https://doi.org/10.1002/ags3.70024","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Robot-assisted surgery has short-term benefits in rectal cancer surgery; however, its long-term advantages remain unclear. This study compared short- and long-term outcomes of open, laparoscopic, and robot-assisted rectal cancer surgeries using large-scale, database-driven evidence.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Patients (28 711) diagnosed with clinical stages I–III rectal cancer who underwent rectal resection and were registered in the Japanese Medical Data Vision Co. Ltd. database were included. Open rectal resection (ORR), laparoscopic rectal resection (LRR), and robot-assisted rectal resection (RARR) were identified. The primary outcomes were 5-year overall survival (OS) and relapse-free survival (RFS). Secondary outcomes included perioperative outcomes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>After applying overlap weight, the RARR, LRR, and ORR groups had 3635 (15.3%), 17 142 (72.3%), and 2935 (12.4%) patients, respectively. Among the cohort (mean age: 69.5 years), 64.9% were male, and 24.7%, 31.5%, and 43.8% had clinical stages I, II, and III, respectively. The RARR group demonstrated the lowest postoperative complication rate, 30- and 90-day mortality rates, and shortest hospital stay. The RARR group had the highest 5-year OS (95%) and RFS (93%) compared to LRR (OS: 89%, RFS: 86%) and ORR (OS: 81%, RFS: 77%; <i>p</i> &lt; 0.001). Multivariable analysis revealed that RARR was significantly associated with improved OS, whereas higher risks were observed for LRR (hazard ratio [HR]: 2.18, 95% confidence interval [CI]: 1.69–2.81) and ORR (HR: 3.96, 95% CI: 3.03–5.19).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The RARR group demonstrated superior short- and long-term outcomes than the LRR and ORR groups, indicating robot-assisted surgery as a potential new standard treatment for rectal cancer.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":"9 5","pages":"1017-1028"},"PeriodicalIF":3.3,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.70024","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145012755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of Gastroenterological Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1